Clinical Trials | December 30, 2025
Senhwa Biosciences launches groundbreaking trial for HER2-positive tumours
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
The expansion includes a larger technical and service team and increased local procurement
GS-098, a first-in-class, humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor, is designed to rapidly block the pathogenic activity of thyroid-stimulating autoantibodies
Subscribe To Our Newsletter & Stay Updated
